Abstract:Vitamin D deficiency (VDD) is prevalent globally and in pediatric intensive care units, where it represents a modifiable risk factor that may impact patient recovery during hospitalization. However, few studies have investigated the dynamic metabolic effects from a single large bolus of enteral cholecalciferol to rapidly restore vitamin D status in critically ill children. Herein, we performed a retrospective analysis of serum samples collected from the VITdALIZE-KIDS pilot study, a phase-II randomized placebo-controlled trial, to elucidate treatment response variations following the intake of 10,000 IU/kg vitamin D3 (up to a maximum of 400,000 IU or 10 mg) by critically ill children with VDD (25-OH-D < 50 nmol/L). Comprehensive vitamin D metabolite and lipidomic studies were performed by reversed-phase ultra-high performance liquid chromatography-mass spectrometry, whereas serum metabolomics and a targeted electrolyte panel were acquired by multisegment injection-capillary electrophoresis-mass spectrometry and capillary electrophoresis with indirect UV detection, respectively. Overall, 6 vitamin D species, 239 lipids, 68 metabolites and 4 electrolytes were measured in most serum samples (> 70%) with adequate precision (CV < 40%) from pooled quality control samples using a multi-step data workflow for molecular feature selection and metabolite authentication. Complementary statistical methods were used to classify circulating metabolites/lipids associated with treatment induced vitamin D sufficiency on day 7 (25-OH-D > 75 nmol/L) following high-dose vitamin D3 intake (n=20) or placebo (n=11) who received a daily maintenance of vitamin D3 (< 1000 IU/day). There was a striking increase in median serum concentrations of 25-OH-D3 (4.7-fold, p = 2.39 x 10-8), 3-epi-25-OH-D3 (24-fold, p = 8.27 x 10-10) and their C3-epimer ratio (6.7-fold, p = 6.22 x 10-5) in treated patients on day 3, whereas serum vitamin D3 levels peaked on day 1 (128-fold, p = 9.11 x 10-8) relative to the standard-of-care. Treatment response differences were largely attributed to differences in oral D3 bioavailability and C3-epimerase activity, but not 25-hydroxylation activity nor baseline calcium or magnesium status. Also, two treated participants were identified as poor responders likely due to malabsorption, and there was no evidence of hypercalcemia in this study. For the first time, we report the detection of circulating 3-epi-D3 that was strongly correlated with vitamin D3 uptake (r = 0.898, p = 3.27 x 10-53), however, its C3-epimer ratio did not change when compared to the daily maintenance therapy as placebo. The systemic metabolic effects of vitamin D sufficiency (serum 25-OH-D > 75 nmol/L on days 2 or 3) corresponded to lower circulating levels of 3-methylhistidine, cystine, S-methylcysteine, uric acid, and two lysophosphatidylcholines (LPC 20:0; LPC 20:2) measured after 7 days with covariate adjustments (p < 0.05; age, sex, weight, and season) relative to vitamin D insufficient patients (serum 25-OH-D < 75 nmol/L). The former three polar metabolites were also significant after adjusting for baseline 25-OH-D status. Overall, serum cystine trajectories were the most sensitive indicator of vitamin D repletion after the first week. Rapid correction of VDD was associated with a metabolic phenotype associated with lower oxidative stress, inflammation, and muscle protein turn-over that may impart clinical benefits.

Changing the tide in vitamin D testing: An 8-year review of a demand management approach

Long-term effects of interventions applied to optimize the use of 25-OH vitamin D tests in primary health care

Vitamin D testing: advantages and limits of the current assays

Strategies To Improve Vitamin D Status In Northern European Children: Exploring The Merits Of Vitamin D Fortification And Supplementation

Reply to Comment on Di Marco, N., Kaufman, J., Rodda, C.P. Shedding Light on Vitamin D Status and Its Complexities during Pregnancy, Infancy and Childhood: An Australian Perspective. Int. J. Environ. Res. Public Health 2019, 16 (4), 538, doi:10.3390/ijerph16040538

Promoting improved utilization of laboratory testing through changes in an electronic medical record: experience at an academic medical center

Did changes to recommended testing criteria affect the rate of vitamin D testing among Australian women

Vitamin D: Update 2013: From rickets prophylaxis to general preventive healthcare

MANAGEMENT OF ENDOCRINE DISEASE: Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency; a position statement of the European Calcified Tissue Society.

Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper

Impact of season and different vitamin D thresholds on prevalence of vitamin D deficiency in epidemiological cohorts—a note of caution

Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement

Vitamin D assay and supplementation: still debatable issues

Optimisation of vitamin D status in global populations

Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients

Seasonal Changes in Vitamin D-Effective UVB Availability in Europe and Associations with Population Serum 25-Hydroxyvitamin D

Metabolomics to Assess Treatment Responses to a Single Large Bolus of Enteral Cholecalciferol in Vitamin D Deficient Critically Ill Children: Insights for Precision Nutrition

Provider Recommendations in the Face of Scientific Uncertainty: An Analysis of Audio-Recorded Discussions about Vitamin D

Navigating complexities in vitamin D and cardiovascular health: a call for comprehensive analysis

Temporal trends and practice variation of paediatric diagnostic tests in primary care

Vitamin D deficiency 2.0: an update on the current status worldwide